Jennifer M Argudo,
Clinical Research Coordinator II
Department:
MD-NEUROMUSCULAR NEUROLOGY
Business Phone:
(352) 733-2413
Business Email:
jenniferargudo@ufl.edu
About Jennifer M Argudo
Jennifer Argudo is a Clinical Research Coordinator II with the Division of Neuromuscular. Jennifer earned her M.D. degree at the University of Cuenca in Ecuador. Since graduating, she has focused her efforts on neurological research due to the beauty and complexity of the human mind. She is passionate about serving others and making a difference in patients’ lives. Movement and neuromuscular disorders are her main areas of interest. In her spare time, she enjoys kayaking, reading, and preparing savory dishes.
Publications
Academic Articles
2022
Adjuvant Treatment for Protocadherin 19 (PCDH19) Syndrome.
Cureus.
14(7)
[DOI] 10.7759/cureus.27154.
[PMID] 36004035.
2022
Arginine for the Treatment of Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes: A Systematic Review.
Cureus.
14(12)
[DOI] 10.7759/cureus.32709.
[PMID] 36686069.
2022
Neuroimaging in the Rare Sleep Disorder of Kleine-Levin Syndrome: A Systematic Review.
Clocks & sleep.
4(2):287-299
[DOI] 10.3390/clockssleep4020025.
[PMID] 35735605.
2022
Relevance of Fluorodopa PET Scan in Dopamine Responsive Dystonia and Juvenile Parkinsonism: A Systematic Review.
Neurology international.
14(4):997-1006
[DOI] 10.3390/neurolint14040079.
[PMID] 36548184.
2022
Understanding Protein Protocadherin-19 (PCDH19) Syndrome: A Literature Review of the Pathophysiology.
Cureus.
14(6)
[DOI] 10.7759/cureus.25808.
[PMID] 35822151.
2022
Use of Levodopa After a Stroke: A Systematic Review.
Cureus.
14(4)
[DOI] 10.7759/cureus.24529.
[PMID] 35651458.
2022
Use of Riluzole for the Treatment of Hereditary Ataxias: A Systematic Review.
Brain sciences.
12(8)
[DOI] 10.3390/brainsci12081040.
[PMID] 36009103.
2022
Vemurafenib in the Treatment of Erdheim Chester Disease: A Systematic Review.
Cureus.
14(6)
[DOI] 10.7759/cureus.25935.
[PMID] 35844342.
Grants
Apr 2024
ACTIVE
Jive: An Open Label Extension Study to Assess the Longterm
Safety, Efficacy, Pharmacodynamics, Pharmacokinetics,
and Tolerability of Subcutaneous CTI-1601 in Subjects with
Friedreichs Ataxia
Role: Other
Funding: LARIMAR THERAPEUTICS
Education
M.D.
2015-2021
·
Universidad de Cuenca
Contact Details
Phones:
- Business:
- (352) 733-2413
Emails:
- Business:
- jenniferargudo@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 112742
GAINESVILLE FL 32611 - Business Street:
-
3009 SW WILLISTON RD
GAINESVILLE FL 32608